Operating Company Consumer

Arcadia Consumer Healthcare

Bridgewater, New Jersey, United States

Arcadia provides simple, efficacious, high quality solutions to help you achieve the harmony of feeling good and looking good.

Focus Areas
Over-the-counter (OTC) medicines, Vitamins & supplements (VMS), Nutraceuticals
Website
arcadiach.com

Tracked deals

3

3 tracked deals across 2020-2023.

Recent pace

0

0 tracked deals announced in the last 12 months.

Deal mix

Addon

2 addon · 1 divestiture

Arcadia Consumer Healthcare Acquisition Volume by Year

Last 2 years

Acquisition volume by year Annual acquisition counts for the last 2 years for Arcadia Consumer Healthcare. 2 2020 1 2023

Supporting Data

Recent Transactions

  • Arcadia Consumer Healthcare (Bansk Group-backed) Acquires Avrio Health Assets
    June 5, 2023
    Buyer
    Arcadia Consumer Healthcare, Bansk Group
    Target
    Avrio Health L.P.
    Seller
    Avrio Health L.P.
    Industry
    Consumer Products
    Location
    New Jersey, United States
    Type
    Addon

    Arcadia Consumer Healthcare, a Bansk Group-backed consumer healthcare platform, has acquired substantially all of the assets of Avrio Health L.P., adding brands including Betadine, Colace, Senokot and SlowMag to its portfolio. The transaction is intended to expand Arcadia's product offerings and leverage its omni-channel distribution and retail relationships to drive growth.

  • Arcadia Consumer Healthcare Acquires NATURELO
    October 15, 2020
    Buyer
    Arcadia Consumer Healthcare, Inc., Avista Capital Partners
    Target
    NATURELO
    Industry
    Consumer Products
    Location
    New Jersey, United States
    Type
    Addon

    Arcadia Consumer Healthcare, a portfolio company of Avista Capital Partners, has acquired NATURELO, a premium vitamins, minerals and supplements (VMS) brand. The add-on expands Arcadia's product portfolio and online presence in the growing self-directed wellness market; financial terms were not disclosed.

  • Arcadia Consumer Healthcare Acquires U.S. Rights to Kaopectate from Sanofi
    March 20, 2020
    Buyer
    Arcadia Consumer Healthcare, Inc., Avista Capital Partners
    Target
    Kaopectate (U.S. rights)
    Seller
    Sanofi
    Industry
    Consumer Products
    Location
    United States
    Type
    Divestiture

    Arcadia Consumer Healthcare, a PE-backed consumer healthcare company, has acquired the U.S. rights to the Kaopectate over-the-counter anti-diarrheal brand from Sanofi. Backed by Avista Capital Partners, Arcadia said it will invest in marketing and innovation to grow the long-established Kaopectate franchise across major U.S. retailers.

Related Acquisition Pages

Consumer Products Buyers & Acquisitions 3 tracked deals by Arcadia Consumer Healthcare. Acquisitions in New Jersey 2 tracked deals by Arcadia Consumer Healthcare.

Related articles

Selling a company? Get in front of buyers like Arcadia Consumer Healthcare

Turn tracked acquisition activity into an outreach-ready buyer list.

Find buyers like these →